level-one heading

Writers
Data Analysts
Consultants
Product Developers
Researchers
Why Kolabtree
Getting started is quick and easy. No upfront fees
It’s free to request a service and invite bids from experts
Discuss requirements with the expert in detail before accepting statement of work from Kolabtree
Collaborate with the expert directly to get your work done the right way
Fund project when you hire the expert, but approve the deliverables only once work is done
Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
★★★★★
☆☆☆☆☆
USD 150 /hr
Hire Dr. Peter V.
Netherlands
USD 150 /hr

MD, PhD, MSc | Epidemiologist & Radiation oncologist with 130+ publications, medical writing / editing expertise

Profile Summary
Subject Matter Expertise
Services
Writing Clinical Trial Documentation, Medical Writing, Technical Writing, General Proofreading & Editing, Translation
Research Meta-Research, Feasibility Study, Scientific and Technical Research, Systematic Literature Review
Consulting Healthcare Consulting
Data & AI Predictive Modeling, Statistical Analysis, Image Processing, Data Visualization, Big Data Analytics, Data Mining, Data Cleaning
Work Experience

Radiation oncologist / Epidemiologist

Amsterdam UMC

January 2022 - Present

Clinical Research Scientist

MD Anderson Cancer Center

June 2022 - December 2022

Resident / Post-doc researcher in Radiation Oncology

UMC Utrecht

June 2016 - May 2022

PhD candidate

UMC Utrecht

January 2013 - September 2016

Education

PhD Medicine

Utrecht University

January 2013 - September 2016

MSc Epidemiology

Utrecht University

September 2013 - October 2015

Medical Degree (MD)

Utrecht University

September 2006 - December 2012

Certifications
  • Certification details not provided.
Publications
JOURNAL ARTICLE
van Laarhoven H, Verhoeven R, van Berge Henegouwen M, Mohammad NH, van Hillegersberg R, Slingerland M, Muijs CT, Wijnhoven B, Mostert B, Beerepoot L, et al.(2025). Real-world outcomes of the CROSS regimen in patients with resectable esophageal or gastro-esophageal junction adenocarcinoma: a nationwide cohort study in the Netherlands . EClinicalMedicine.
Abana, C.O., Carriere, P.P., Damen, P.J., van Rossum, P.S.N., Yoder, A.K., Bravo, P.L., Wei, X., Pollard-Larkin, J.M., Nitsch, P.L., Murphy, M.B., et al.(2025). Comparative Outcomes and Toxicity in Patients With Esophageal Cancer After Trimodality Therapy With Step-and-Shoot Intensity-Modulated Radiation Therapy Versus Volumetric Modulated Arc Therapy: The MD Anderson Experience . Clinical Oncology. 38.
Kroese, T.E., Bronzwaer, S.F.C., van Rossum, P.S.N., van Laarhoven, H.W.M., van Hillegersberg, R.(2025). Oligometastatic Esophagogastric Cancer: Does It Exist and How Do We Treat It? . Current Oncology Reports. 27. (1). p. 30-36.
Webster, A., Fog, L.S., Hall, E., van Rossum, P.S.N., Nevens, D., Montay-Gruel, P., Franco, P., Joyce, E., Jornet, N., Clark, C.H., et al.(2025). ESTRO guidelines for developing questionnaires in survey-based radiation oncology research . Clinical and Translational Radiation Oncology. 51.
Damen, P.J.J., Peters, M., Hobbs, B., Chen, Y., Titt, U., Nout, R., Mohan, R., Lin, S.H., van Rossum, P.S.N.(2025). Defining the Optimal Radiation-induced Lymphopenia Metric to Discern Its Survival Impact in Esophageal Cancer . International Journal of Radiation Oncology Biology Physics. 122. (1). p. 31-42.
van Laarhoven, H., Verhoeven, R., van Berge Henegouwen, M., Mohammad, N.H., van Hillegersberg, R., Slingerland, M., Muijs, C.T., Wijnhoven, B., Mostert, B., Beerepoot, L., et al.(2025). Real-world outcomes of the CROSS regimen in patients with resectable esophageal or gastro-esophageal junction adenocarcinoma: a nationwide cohort study in the Netherlands . eClinicalMedicine. 80.
Webster A, Fog LS, Hall E, van Rossum PSN, Nevens D, Montay-Gruel P, Franco P, Joyce E, Jornet N, Clark CH, et al.(2024). ESTRO guidelines for developing questionnaires in survey-based radiation oncology research . Clinical and translational radiation oncology.
Peter S.N. van Rossum, Nienke Wolfhagen, Liselotte W. van Bockel, Ida E.M. Coremans, Corine A. van Es, Annelies M. van der Geest, Katrien E.A. De Jaeger, Barbara Wachters, Hans P. Knol, Friederike L.A. Koppe, et al. (2024). Real-World Acute Toxicity and 90-Day Mortality in Patients With Stage I NSCLC Treated With Stereotactic Body Radiotherapy . Journal of Thoracic Oncology.
Peter S.N. van Rossum, Nienke Wolfhagen, Ronald A.M. Damhuis, José S.A. Belderbos (2024). An In-Depth Discussion on Dutch Prediction Models for Relevant Acute Toxicity and 90-Day Mortality After Stereotactic Body Radiotherapy for Stage I NSCLC . Journal of Thoracic Oncology.
Hu Z, Mohan R, Chu Y, Wang X, van Rossum PSN, Chen Y, Grayson ME, Gearhardt AG, Grassberger C, Zhi D, et al.(2024). Clinical Translation of a Deep Learning Model of Radiation-Induced Lymphopenia for Esophageal Cancer . International journal of particle therapy.
Chen Y, Chu Y, van Rossum PSN, Grassberger C, Lin SH, Mohan R, Hobbs BP(2024). Radiation-Induced Lymphopenia is a Causal Mediator of Survival After Chemoradiation Therapy for Esophagus Cancer . Advances in radiation oncology.
Damen PJJ, van Rossum PSN, Chen Y, Abana CO, Liao Z, Hobbs BP, Mohan R, Blum-Murphy M, Hofstetter WL, Lin SH(2024). Comparing 90-Day Postoperative Mortality After Neoadjuvant Proton-Based Versus Photon-Based Chemoradiotherapy for Esophageal Cancer . International journal of particle therapy.
Damen, P.J.J., van Rossum, P.S.N., Chen, Y., Abana, C.O., Liao, Z., Hobbs, B.P., Mohan, R., Blum-Murphy, M., Hofstetter, W.L., Lin, S.H.(2024). Comparing 90-Day Postoperative Mortality After Neoadjuvant Proton-Based Versus Photon-Based Chemoradiotherapy for Esophageal Cancer . International Journal of Particle Therapy. 11.
Palma, D.A., Giuliani, M.E., Correa, R.J.M., Schneiders, F.L., Harrow, S., Guckenberger, M., Zhang, T., Bahig, H., Senthi, S., Chung, P., et al.(2024). A randomized phase III trial of stereotactic ablative radiotherapy for patients with up to 10 oligometastases and a synchronous primary tumor (SABR-SYNC): study protocol . BMC Palliative Care. 23. (1).
Damen, P.J.J., Lin, S.H., van Rossum, P.S.N.(2024). Editorial: Updates on radiation-induced lymphopenia . Frontiers in Oncology. 14.
Abana, C.O., Damen, P.J., van Rossum, P.S., Bravo, P.L., Wei, X., Pollard-Larkin, J.M., Nitsch, P.L., Murphy, M.B., Hofstetter, W.L., Liao, Z., et al.(2024). Esophageal Cancer Outcomes After Definitive Chemotherapy With Intensity Modulated Proton Therapy . International Journal of Particle Therapy. 11.
Chu, Y., Zhu, C., Hobbs, B.P., Chen, Y., van Rossum, P.S.N., Grassberger, C., Zhi, D., Lin, S.H., Mohan, R.(2024). Personalized Composite Dosimetric Score-Based Machine Learning Model of Severe Radiation-Induced Lymphopenia Among Patients With Esophageal Cancer . International Journal of Radiation Oncology Biology Physics. 120. (4). p. 1172-1180.
Wang, X., van Rossum, P.S.N., Chu, Y., Hobbs, B.P., Grassberger, C., Hong, T.S., Liao, Z., Yang, J., Zhang, X., Netherton, T., et al.(2024). Severe Lymphopenia During Chemoradiation Therapy for Esophageal Cancer: Comprehensive Analysis of Randomized Phase 2B Trial of Proton Beam Therapy Versus Intensity Modulated Radiation Therapy . International Journal of Radiation Oncology Biology Physics. 118. (2). p. 368-377.
Kroese, T.E., Bronzwaer, S., van Rossum, P.S.N., Schoppman, S.F., Deseyne, P.R.A.J., van Cutsem, E., Haustermans, K., Nafteux, P., Thomas, M., Obermannova, R., et al.(2024). European clinical practice guidelines for the definition, diagnosis, and treatment of oligometastatic esophagogastric cancer (OMEC-4) . European Journal of Cancer. 204.
Janssens, G.O., Timmermann, B., Laprie, A., Mandeville, H., Padovani, L., Chargari, C., Kearns, P., Kozhaeva, O., Kameric, L., Kienesberger, A., et al.(2024). The organization of care in pediatric radiotherapy across SIOP Europe affiliated centers: A multicenter survey in the framework of the ‘Joint Action on Rare Cancers’ project . Radiotherapy and Oncology. 191.
Merckel, L.G., Pomp, J., Hackett, S.L., van Lier, A.L.H.M.W., van den Dobbelsteen, M., Rasing, M.J.A., Mohamed Hoesein, F.A.A., Snoeren, L.M.W., van Es, C.A., van Rossum, P.S.N., et al.(2024). Stereotactic body radiotherapy of central lung tumours using a 1.5 T MR-linac: First clinical experiences . Clinical and Translational Radiation Oncology. 45.
Hu, Z., Mohan, R., Chu, Y., Wang, X., van Rossum, P.S.N., Chen, Y., Grayson, M.E., Gearhardt, A.G., Grassberger, C., Zhi, D., et al.(2024). Clinical Translation of a Deep Learning Model of Radiation-Induced Lymphopenia for Esophageal Cancer . International Journal of Particle Therapy. 13.
Chen, Y., Chu, Y., van Rossum, P.S.N., Grassberger, C., Lin, S.H., Mohan, R., Hobbs, B.P.(2024). Radiation-Induced Lymphopenia is a Causal Mediator of Survival After Chemoradiation Therapy for Esophagus Cancer . Advances in Radiation Oncology. 9. (10).
van Rossum, P.S.N., Wolfhagen, N., Damhuis, R.A.M., Belderbos, J.S.A.(2024). An In-Depth Discussion on Dutch Prediction Models for Relevant Acute Toxicity and 90-Day Mortality After Stereotactic Body Radiotherapy for Stage I NSCLC . Journal of Thoracic Oncology. 19. (11). p. e74-e77.
van Rossum, P.S.N., Wolfhagen, N., van Bockel, L.W., Coremans, I.E.M., van Es, C.A., van der Geest, A.M., De Jaeger, K.E.A., Wachters, B., Knol, H.P., Koppe, F.L.A., et al.(2024). Real-World Acute Toxicity and 90-Day Mortality in Patients With Stage I NSCLC Treated With Stereotactic Body Radiotherapy . Journal of Thoracic Oncology. 19. (11). p. 1550-1563.
Peters M, Boersma HW, van Rossum PSN, van Oort J, Cahn W, Verhoeff JJC(2023). The impact of schizophrenia spectrum disorder, bipolar disorder and borderline personality disorder on radiotherapy treatment and overall survival in cancer patients: A matched pair analysis . Clinical and translational radiation oncology.
Peters, M., Boersma, H.W., van Rossum, P.S.N., van Oort, J., Cahn, W., Verhoeff, J.J.C.(2023). The impact of schizophrenia spectrum disorder, bipolar disorder and borderline personality disorder on radiotherapy treatment and overall survival in cancer patients: A matched pair analysis . Clinical and Translational Radiation Oncology. 40.
van Laarhoven, H.W.M., van Rossum, P.S.N.(2023). Adding PD-1 inhibition to chemoradiotherapy for oesophageal cancer . The Lancet Oncology. 24. (4). p. 309-310.
Ellsworth, S.G., van Rossum, P.S.N., Mohan, R., Lin, S.H., Grassberger, C., Hobbs, B.(2023). Declarations of Independence: How Embedded Multicollinearity Errors Affect Dosimetric and Other Complex Analyses in Radiation Oncology . International Journal of Radiation Oncology Biology Physics. 117. (5). p. 1054-1062.
van Rossum, P.S.N., van Laarhoven, H.W.M.(2023). CROSS versus modified MAGIC or FLOT in oesophageal and gastro-oesophageal junction adenocarcinoma . The Lancet Gastroenterology and Hepatology. 8. (11). p. 959-960.
Rakauskas, A., Peters, M., Martel, P., van Rossum, P.S.N., La Rosa, S., Meuwly, J.-Y., Roth, B., Valerio, M.(2023). Do cancer detection rates differ between transperineal and transrectal micro-ultrasound mpMRI-fusion-targeted prostate biopsies? A propensity score-matched study . PLoS ONE. 18. (1 January).
Kroese, T.E., van Laarhoven, H.W.M., Schoppman, S.F., Deseyne, P.R.A.J., van Cutsem, E., Haustermans, K., Nafteux, P., Thomas, M., Obermannova, R., Mortensen, H.R., et al.(2023). Definition, diagnosis and treatment of oligometastatic oesophagogastric cancer: A Delphi consensus study in Europe . European Journal of Cancer. 185. p. 28-39.
Habashy, D., Reddy, D., Peters, M., Shah, T.T., Van Son, M., Van Rossum, P.S.N., Tanaka, M.B., Cullen, E., Engle, R., McCracken, S., et al.(2023). Evaluation of Outcomes Following Focal Ablative Therapy for Treatment of Localized Clinically Significant Prostate Cancer in Patients 70 Years: A Multi-institute, Multi-energy 15-Year Experience . Journal of Urology. 210. (1). p. 108-115.
Tomassen, M.L., Damen, P.J.J., Verkooijen, H.M., Peters, M., van der Stap, J., van Lindert, A.S.R., Verhoeff, J.J.C., van Rossum, P.S.N.(2023). Feasibility and first results of the ‘Trials-within-Cohorts’ (TwiCs) design in patients undergoing radiotherapy for lung cancer . Acta Oncologica. 62. (3). p. 237-244.
Pape, M., Veen, L.M., Smit, T.M., Kuijper, S.C., Vissers, P.A.J., Geijsen, E.D., van Rossum, P.S.N., Sprangers, M.A.G., Derks, S., Verhoeven, R.H.A., et al.(2023). Late Toxicity and Health-Related Quality of Life Following Definitive Chemoradiotherapy for Esophageal Cancer: A Systematic Review and Meta-analysis . International Journal of Radiation Oncology Biology Physics. 117. (1). p. 31-44.
Kroese, T.E., Takahashi, Y., Lordick, F., van Rossum, P.S.N., Ruurda, J.P., Lagarde, S.M., van Hillegersberg, R., Verhoeven, R.H.A., van Laarhoven, H.W.M.(2023). Liver oligometastatic disease in synchronous metastatic gastric cancer patients: a nationwide population-based cohort study . European Journal of Cancer. 179. p. 65-75.
Pape, M., Vissers, P.A.J., Slingerland, M., Haj Mohammad, N., van Rossum, P.S.N., Verhoeven, R.H.A., van Laarhoven, H.W.M.(2023). Long-term health-related quality of life in patients with advanced esophagogastric cancer receiving first-line systemic therapy . Supportive Care in Cancer. 31. (9).
van der Horst, S., Weijs, T.J., Braunius, W.W., Mook, S., Mohammed, N.H., Brosens, L., van Rossum, P.S.N., Weusten, B.L.A.M., Ruurda, J.P., van Hillegersberg, R.(2023). Safety and Feasibility of Robot-Assisted Minimally Invasive Esophagectomy (RAMIE) with Three-Field Lymphadenectomy and Neoadjuvant Chemoradiotherapy in Patients with Resectable Esophageal Cancer and Cervical Lymph Node Metastasis . Annals of Surgical Oncology. 30. (5). p. 2743-2752.
van Rossum, P.S.N., Juan-Cruz, C., Stam, B., Rossi, M.M.G., Lin, S.H., Abravan, A., Belderbos, J.S.A., Sonke, J.-J.(2023). Severe radiation-induced lymphopenia during concurrent chemoradiotherapy for stage III non-small cell lung cancer: external validation of two prediction models . Frontiers in Oncology. 13.
Kroese, T.E., van Rossum, P.S.N., Nilsson, M., Lordick, F., Smyth, E.C., Rosati, R., Nafteux, P., D'Ugo, D., Chaudry, M.A., Polkowkski, W., et al.(2023). Study protocol for the OligoMetastatic Esophagogastric Cancer (OMEC) project: A multidisciplinary European consensus project on the definition and treatment for oligometastatic esophagogastric cancer . European Journal of Surgical Oncology. 49. (1). p. 21-28.
Rasing MJA, Sikkes GG, Vissers NGPM, Kotte ANTJ, Boudewijn JH, Doornaert PAH, Eppinga WSC, Intven M, Rutgers RHA, Scheeren A, et al.(2022). Online adaptive MR-guided radiotherapy: Conformity of contour adaptation for prostate cancer, rectal cancer and lymph node oligometastases among radiation therapists and radiation oncologists . Technical innovations & patient support in radiation oncology.
Kroese TE, Jorritsma NKN, van Laarhoven HWM, Verhoeven RHA, Mook S, Haj Mohammad N, Ruurda JP, van Rossum PSN, van Hillegersberg R(2022). Stereotactic radiotherapy or metastasectomy for oligometastatic esophagogastric cancer: A nationwide population-based cohort study . Clinical and translational radiation oncology.
Kroese TE, van Rossum PSN, van der Horst S, Mook S, Haj Mohammad N, Ruurda JP, van Hillegersberg R(2022). Long-term survival after sequential local treatments for oligometastatic esophageal squamous cell carcinoma: A case report . International journal of surgery case reports.
Bukkems LJH, Jürgenliemk-Schulz IM, van der Leij F, Peters M, Gerestein CG, Zweemer RP, van Rossum PSN(2022). The impact of para-aortic lymph node irradiation on disease-free survival in patients with cervical cancer: A systematic review and meta-analysis . Clinical and translational radiation oncology.
Kroese TE, Ruurda JP, Bakker AS, Jairam J, Mook S, van der Horst S, Meijer GJ, Haj Mohammad N, van Rossum PSN, van Hillegersberg R(2022). Detecting Interval Distant Metastases With 18F-FDG PET/CT After Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Cancer . Clinical nuclear medicine.
Tomassen ML, Pomp J, van der Stap J, van Lindert ASR, Peters M, Belderbos JSA, De Ruysscher DKM, Lin SH, Verhoeff JJC, van Rossum PSN(2022). The overall survival impact of prophylactic cranial irradiation in limited-stage small-cell lung cancer: A systematic review and meta-analysis . Clinical and translational radiation oncology.
Tomassen, M.L., Pomp, J., van der Stap, J., van Lindert, A.S.R., Peters, M., Belderbos, J.S.A., De Ruysscher, D.K.M., Lin, S.H., Verhoeff, J.J.C., van Rossum, P.S.N.(2022). The overall survival impact of prophylactic cranial irradiation in limited-stage small-cell lung cancer: A systematic review and meta-analysis . Clinical and Translational Radiation Oncology. 33. p. 145-152.
Dijksterhuis, W.P.M., Kroese, T.E., Verhoeven, R.H.A., van Rossum, P.S.N., Mook, S., Haj Mohammad, N., Hulshof, M.C.C.M., Gisbertz, S.S., Ruurda, J.P., van Oijen, M.G.H., et al.(2022). A population-based study on treatment and outcomes in patients with gastric adenocarcinoma diagnosed with distant interval metastases . European Journal of Surgical Oncology. 48. (9). p. 1964-1971.
Kroese, T.E., van Rossum, P.S.N., van Hillegersberg, R.(2022). ASO Author Reflections: Role of Local Treatment for Oligometastatic Esophagogastric Cancer . Annals of Surgical Oncology. 29. (8). p. 4858-4860.
Rasing, M.J.A., Peters, M., Aarts, M.J., Herder, G.J.M., van Lindert, A.S.R., Schramel, F.M.N.H., van der Meer, F.S., Verhoeff, J.J.C., van Rossum, P.S.N.(2022). Adjuvant Treatment Following Irradical Resection of Stage I-III Non-small Cell Lung Cancer: A Population-based Study . Current Problems in Cancer. 46. (1).
Kroese, T.E., van Laarhoven, H.W.M., Nilsson, M., Lordick, F., Guckenberger, M., Ruurda, J.P., D'Ugo, D., Haustermans, K., van Cutsem, E., van Hillegersberg, R., et al.(2022). Definition of oligometastatic esophagogastric cancer and impact of local oligometastasis-directed treatment: A systematic review and meta-analysis . European Journal of Cancer. 166. p. 254-269.
Kroese, T.E., van Hillegersberg, R., Schoppmann, S., Deseyne, P.R.A.J., Nafteux, P., Obermannova, R., Nordsmark, M., Pfeiffer, P., Hawkings, M.A., Smyth, E., et al.(2022). Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe . European Journal of Cancer. 164. p. 18-29.
Damen, P.J.J., Kroese, T.E., Peters, M., Lin, S.H., Verhoeff, J.J.C., van Rossum, P.S.N.(2022). In Reply to Chow and Simone . International Journal of Radiation Oncology Biology Physics. 113. (1). p. 236-237.
Kroese, T.E., Christ, S.M., van Rossum, P.S.N., Burger, M.D.L., Buijs, G.S., Mühlematter, U., Andratschke, N., Ruurda, J.P., Hüllner, M., Gutschow, C.A., et al.(2022). Incidence and survival of patients with oligometastatic esophagogastric cancer: A multicenter cohort study . Radiotherapy and Oncology. 173. p. 269-276.
Kroese, T.E., Buijs, G.S., Burger, M.D.L., Ruurda, J.P., Mook, S., Brosens, L.A.A., van Rossum, P.S.N., van Hillegersberg, R.(2022). Metastasectomy or Stereotactic Body Radiation Therapy With or Without Systemic Therapy for Oligometastatic Esophagogastric Cancer . Annals of Surgical Oncology. 29. (8). p. 4848-4857.
van Joolingen, W.H., Rasing, M.J.A., Peters, M., van Lindert, A.S.R., de Heer, L.M., Aarts, M.J., Verhoeff, J.J.C., van Rossum, P.S.N.(2022). Non-Small-Cell Lung Cancer Patients with a High Predicted Risk of Irradical Resection: Can Chemoradiotherapy Offer Similar Survival? . Annals of Surgical Oncology. 29. (3). p. 1807-1814.
Peters, M., Eldred-Evans, D., Kurver, P., Falagario, U.G., Connor, M.J., Shah, T.T., Verhoeff, J.J.C., Taimen, P., Aronen, H.J., Knaapila, J., et al.(2022). Predicting the Need for Biopsy to Detect Clinically Significant Prostate Cancer in Patients with a Magnetic Resonance Imaging–detected Prostate Imaging Reporting and Data System/Likert ≥3 Lesion: Development and Multinational External Validation of the Imperial Rapid Access to Prostate Imaging and Diagnosis Risk Score . European Urology. 82. (5). p. 559-568.
Thelissen, A.A.B., Jürgenliemk-Schulz, I.M., van der Leij, F., Peters, M., Gerestein, C.G., Zweemer, R.P., van Rossum, P.S.N.(2022). Upstaging by para-aortic lymph node dissection in patients with locally advanced cervical cancer: A systematic review and meta-analysis . Gynecologic Oncology. 164. (3). p. 667-674.
Hack, A.P., Zweemer, R.P., Jonges, T.N., van der Leij, F., Gerestein, C.G., Peters, M., Jürgenliemk-Schulz, I.M., van Rossum, P.S.N.(2022). Prognostic impact of waiting time between diagnosis and treatment in patients with cervical cancer: A nationwide population-based study . Gynecologic Oncology. 165. (2). p. 339-346.
Kroese, T.E., Jorritsma, N.K.N., van Laarhoven, H.W.M., Verhoeven, R.H.A., Mook, S., Haj Mohammad, N., Ruurda, J.P., van Rossum, P.S.N., van Hillegersberg, R.(2022). Stereotactic radiotherapy or metastasectomy for oligometastatic esophagogastric cancer: A nationwide population-based cohort study . Clinical and Translational Radiation Oncology. 37. p. 109-115.
Rasing, M.J.A., Sikkes, G.G., Vissers, N.G.P.M., Kotte, A.N.T.J., Boudewijn, J.H., Doornaert, P.A.H., Eppinga, W.S.C., Intven, M., Rutgers, R.H.A., Scheeren, A., et al.(2022). Online adaptive MR-guided radiotherapy: Conformity of contour adaptation for prostate cancer, rectal cancer and lymph node oligometastases among radiation therapists and radiation oncologists . Technical Innovations and Patient Support in Radiation Oncology. 23. p. 33-40.
Kroese, T.E., Ruurda, J.P., Bakker, A.S., Jairam, J., Mook, S., Van Der Horst, S., Meijer, G.J., Haj Mohammad, N., Van Rossum, P.S.N., Van Hillegersberg, R.(2022). Detecting Interval Distant Metastases With <sup>18</sup>F-FDG PET/CT After Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Cancer . Clinical Nuclear Medicine. 47. (6). p. 496-502.
Bukkems, L.J.H., J&#252;rgenliemk-Schulz, I.M., van der Leij, F., Peters, M., Gerestein, C.G., Zweemer, R.P., van Rossum, P.S.N.(2022). The impact of para-aortic lymph node irradiation on disease-free survival in patients with cervical cancer: A systematic review and meta-analysis . Clinical and Translational Radiation Oncology. 35. p. 97-103.
Kroese, T.E., van Rossum, P.S.N., van der Horst, S., Mook, S., Haj Mohammad, N., Ruurda, J.P., van Hillegersberg, R.(2022). Long-term survival after sequential local treatments for oligometastatic esophageal squamous cell carcinoma: A case report . International Journal of Surgery Case Reports. 97.
Mul J, Melchior P, Seravalli E, Saunders D, Bolle S, Cameron AL, Gurtner K, Harrabi S, Lassen-Ramshad Y, Lavan N, et al.(2021). Inter-clinician delineation variation for a new highly-conformal flank target volume in children with renal tumors: A SIOP-Renal Tumor Study Group international multicenter exercise . Clinical and translational radiation oncology.
Tomassen ML, Aarts MJ, Peters M, van Lindert A, De Ruysscher DKM, Verhoeff JJC, van Rossum PSN(2021). Prophylactic cranial irradiation in patients with small cell lung cancer in The Netherlands: A population-based study . Clinical and translational radiation oncology.
Mul, J., Melchior, P., Seravalli, E., Saunders, D., Bolle, S., Cameron, A.L., Gurtner, K., Harrabi, S., Lassen-Ramshad, Y., Lavan, N., et al.(2021). Inter-clinician delineation variation for a new highly-conformal flank target volume in children with renal tumors: A SIOP-Renal Tumor Study Group international multicenter exercise . Clinical and Translational Radiation Oncology. 28. p. 39-47.
Khoo, C.C., Eldred-Evans, D., Peters, M., Van Son, M., Van Rossum, P.S.N., Connor, M.J., Hosking-Jervis, F., Tanaka, M.B., Reddy, D., Bass, E., et al.(2021). A Comparison of Prostate Cancer Detection between Visual Estimation (Cognitive Registration) and Image Fusion (Software Registration) Targeted Transperineal Prostate Biopsy . Journal of Urology. 205. (4). p. 1075-1081.
Tomassen, M.L., Aarts, M.J., Peters, M., van Lindert, A., De Ruysscher, D.K.M., Verhoeff, J.J.C., van Rossum, P.S.N.(2021). Prophylactic cranial irradiation in patients with small cell lung cancer in The Netherlands: A population-based study . Clinical and Translational Radiation Oncology. 27. p. 157-163.
van Houtum, Q.Q., Mohamed Hoesein, F.F.A.A., Verhoeff, J.J.J.C., van Rossum, P.P.S.N., van Lindert, A.A.S.R., van der Velden, T.T.A., van der Kemp, W.W.J.M., Klomp, D.D.W.J., Arteaga de Castro, C.C.S.(2021). Feasibility of <sup>31</sup>P spectroscopic imaging at 7 T in lung carcinoma patients . NMR in Biomedicine. 34. (5).
Shah, T.T., Reddy, D., Peters, M., Ball, D., Kim, N.H., Gomez, E.G., Miah, S., Evans, D.E., Guillaumier, S., van Rossum, P.S.N., et al.(2021). Focal therapy compared to radical prostatectomy for non-metastatic prostate cancer: a propensity score-matched study . Prostate Cancer and Prostatic Diseases. 24. (2). p. 567-574.
Rasing, M.J.A., Peters, M., Moreno, A.C., Hofman, E.F.N., Herder, G.J.M., Welvaart, P.W.N., Schramel, F.M.N.H., Lodeweges, J.E., Lin, S.H., Verhoeff, J.J.C., et al.(2021). Predicting Incomplete Resection in Non-Small Cell Lung Cancer Preoperatively: A Validated Nomogram . Annals of Thoracic Surgery. 111. (3). p. 1052-1058.
van Rossum, P.S.N., Jeene, P.M., Rozema, T., Braam, P.M., Lips, I.M., Muller, K., van Kampen, D., Vermeulen, B.D., Homs, M.Y.V., Oppedijk, V., et al.(2021). Patient-reported outcomes after external beam radiotherapy versus brachytherapy for palliation of dysphagia in esophageal cancer: A matched comparison of two prospective trials . Radiotherapy and Oncology. 155. p. 73-79.
Peters, M., de Leeuw, A.A.C., Nomden, C.N., Tanderup, K., Kirchheiner, K., Lindegaard, J.C., Kirisits, C., Haie-Meder, C., Sturdza, A., Fokdal, L., et al.(2021). Risk factors for nodal failure after radiochemotherapy and image guided brachytherapy in locally advanced cervical cancer: An EMBRACE analysis . Radiotherapy and Oncology. 163. p. 150-158.
Kroese, T.E., Jairam, J., Ruurda, J.P., Lin, S.H., Mohan, R., Mook, S., Haitjema, S., Hoefer, I., Haj Mohammad, N., Peters, M., et al.(2021). Severe lymphopenia acquired during chemoradiotherapy for esophageal cancer: Incidence and external validation of a prediction model . Radiotherapy and Oncology. 163. p. 192-198.
Damen, P.J.J., Kroese, T.E., van Hillegersberg, R., Schuit, E., Peters, M., Verhoeff, J.J.C., Lin, S.H., van Rossum, P.S.N.(2021). The Influence of Severe Radiation-Induced Lymphopenia on Overall Survival in Solid Tumors: A Systematic Review and Meta-Analysis . International Journal of Radiation Oncology Biology Physics. 111. (4). p. 936-948.
Lodeweges, J.E., van Rossum, P.S.N., Bartels, M.M.T.J., van Lindert, A.S.R., Pomp, J., Peters, M., Verhoeff, J.J.C.(2021). Ultra-central lung tumors: safety and efficacy of protracted stereotactic body radiotherapy . Acta Oncologica. 60. (8). p. 1061-1068.
Borggreve AS, Goense L, van Rossum PSN, Heethuis SE, van Hillegersberg R, Lagendijk JJW, Lam MGEH, van Lier ALHMW, Mook S, Ruurda JP, et al.(2020). Preoperative Prediction of Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients With Esophageal Cancer Using <sup>18</sup>F-FDG PET/CT and DW-MRI: A Prospective Multicenter Study . International journal of radiation oncology, biology, physics.
Borggreve, A.S., Goense, L., van Rossum, P.S.N., Heethuis, S.E., van Hillegersberg, R., Lagendijk, J.J.W., Lam, M.G.E.H., van Lier, A.L.H.M.W., Mook, S., Ruurda, J.P., et al.(2020). Preoperative Prediction of Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients With Esophageal Cancer Using <sup>18</sup>F-FDG PET/CT and DW-MRI: A Prospective Multicenter Study . International Journal of Radiation Oncology Biology Physics. 106. (5). p. 998-1009.
Borggreve, A.S., Heethuis, S.E., Boekhoff, M.R., Goense, L., van Rossum, P.S.N., Brosens, L.A.A., van Lier, A.L.H.M.W., van Hillegersberg, R., Lagendijk, J.J.W., Mook, S., et al.(2020). Optimal timing for prediction of pathologic complete response to neoadjuvant chemoradiotherapy with diffusion-weighted MRI in patients with esophageal cancer . European Radiology. 30. (4). p. 1896-1907.
Jeene, P.M., Vermeulen, B.D., Rozema, T., Braam, P.M., Lips, I., Muller, K., van Kampen, D., Homs, M.Y.V., Oppedijk, V., Berb&#233;e, M., et al.(2020). Short-Course External Beam Radiotherapy Versus Brachytherapy for Palliation of Dysphagia in Esophageal Cancer: A Matched Comparison of Two Prospective Trials . Journal of Thoracic Oncology. 15. (8). p. 1361-1368.
van Rossum, P.S.N., Deng, W., Routman, D.M., Liu, A.Y., Xu, C., Shiraishi, Y., Peters, M., Merrell, K.W., Hallemeier, C.L., Mohan, R., et al.(2020). Prediction of Severe Lymphopenia During Chemoradiation Therapy for Esophageal Cancer: Development and Validation of a Pretreatment Nomogram . Practical Radiation Oncology. 10. (1). p. e16-e26.
van Rossum PSN, Deng W, Routman DM, Liu AY, Xu C, Shiraishi Y, Peters M, Merrell KW, Hallemeier CL, Mohan R, et al.(2019). Prediction of Severe Lymphopenia During Chemoradiation Therapy for Esophageal Cancer: Development and Validation of a Pretreatment Nomogram . Practical radiation oncology.
Vollenbrock SE, Nowee ME, Voncken FEM, Kotte ANTJ, Goense L, van Rossum PSN, van Lier ALHMW, Heijmink SW, Bartels-Rutten A, Wessels FJ, et al.(2019). Gross Tumor Delineation in Esophageal Cancer on MRI Compared With <sup>18</sup>F-FDG-PET/CT . Advances in radiation oncology.
Borggreve AS, Goense L, Brenkman HJF, Mook S, Meijer GJ, Wessels FJ, Verheij M, Jansen EPM, van Hillegersberg R, van Rossum PSN, et al.(2019). Imaging strategies in the management of gastric cancer: current role and future potential of MRI . The British journal of radiology.
Borggreve, A.S., Goense, L., Brenkman, H.J.F., Mook, S., Meijer, G.J., Wessels, F.J., Verheij, M., Jansen, E.P.M., Van Hillegersberg, R., Van Rossum, P.S.N., et al.(2019). Imaging strategies in the management of gastric cancer: Current role and future potential of MRI . British Journal of Radiology. 92. (1097).
Borggreve, A.S., van Rossum, P.S.N., Mook, S., Haj Mohammad, N., van Hillegersberg, R., Ruurda, J.P.(2019). Frequency of surgical resection after starting neoadjuvant chemoradiotherapy in patients with esophageal cancer: A population-based cohort study . European Journal of Surgical Oncology. 45. (10). p. 1919-1925.
Shah, T.T., Gao, C., Peters, M., Manning, T., Cashman, S., Nambiar, A., Cumberbatch, M., Lamb, B., Peacock, A., Van Son, M.J., et al.(2019). Factors associated with spontaneous stone passage in a contemporary cohort of patients presenting with acute ureteric colic: results from the Multi-centre cohort study evaluating the role of Inflammatory Markers In patients presenting with acute ureteric Colic (MIMIC) study . BJU International. 124. (3). p. 504-513.
Nowee, M.E., Voncken, F.E.M., Kotte, A.N.T.J., Goense, L., van Rossum, P.S.N., van Lier, A.L.H.M.W., Heijmink, S.W., Aleman, B.M.P., Nijkamp, J., Meijer, G.J., et al.(2019). Gross tumour delineation on computed tomography and positron emission tomography-computed tomography in oesophageal cancer: A nationwide study . Clinical and Translational Radiation Oncology. 14. p. 33-39.
Thomas, M., Borggreve, A.S., van Rossum, P.S.N., Perneel, C., Moons, J., Van Daele, E., van Hillegersberg, R., Deng, W., Pattyn, P., Mook, S., et al.(2019). Radiation dose and pathological response in oesophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by surgery: a multi-institutional analysis . Acta Oncologica. 58. (10). p. 1358-1365.
Deng, W., Xu, C., Liu, A., van Rossum, P.S.N., Deng, W., Liao, Z., Koong, A.C., Mohan, R., Lin, S.H.(2019). The relationship of lymphocyte recovery and prognosis of esophageal cancer patients with severe radiation-induced lymphopenia after chemoradiation therapy . Radiotherapy and Oncology. 133. p. 9-15.
Vollenbrock, S.E., Nowee, M.E., Voncken, F.E.M., Kotte, A.N.T.J., Goense, L., van Rossum, P.S.N., van Lier, A.L.H.M.W., Heijmink, S.W., Bartels-Rutten, A., Wessels, F.J., et al.(2019). Gross Tumor Delineation in Esophageal Cancer on MRI Compared With <sup>18</sup>F-FDG-PET/CT . Advances in Radiation Oncology. 4. (4). p. 596-604.
Visser, E., van Rossum, P.S.N., van Veer, H., Al-Naimi, K., Chaudry, M.A., Cuesta, M.A., Gisbertz, S.S., Gutschow, C.A., H&#246;lscher, A.H., Luyer, M.D.P., et al.(2018). A structured training program for minimally invasive esophagectomy for esophageal cancer-a Delphi consensus study in Europe . Diseases of the Esophagus. 31. (3).
Goense, L., Meziani, J., van Rossum, P.S.N., Wessels, F.J., Lam, M.G.E.H., van Hillegersberg, R., Ruurda, J.P.(2018). Cervical ultrasonography has no additional value over negative <sup>18</sup>F-FDG PET/CT scans for diagnosing cervical lymph node metastases in patients with oesophageal cancer . European Radiology. 28. (5). p. 2031-2037.
Goense, L., Heethuis, S.E., Van Rossum, P.S.N., Voncken, F.E.M., Lagendijk, J.J.W., Lam, M.G.E.H., Terhaard, C.H., Van Hillegersberg, R., Ruurda, J.P., Mook, S., et al.(2018). Correlation between functional imaging markers derived from diffusion-weighted MRI and 18 F-FDG PET/CT in esophageal cancer . Nuclear Medicine Communications. 39. (1). p. 60-67.
Visser, E., Marsman, M., van Rossum, P.S.N., Cheong, E., Al-Naimi, K., van Klei, W.A., Ruurda, J.P., van Hillegersberg, R.(2018). Corrigendum: Postoperative pain management after esophagectomy: A systematic review and meta-analysis [Diseases of the Esophagus, 30, 10, (2017) (1-11)] DOI: 10.1093/dote/dox052 . Diseases of the Esophagus. 31. (4).
Heethuis, S.E., Goense, L., van Rossum, P.S.N., Borggreve, A.S., Mook, S., Voncken, F.E.M., Bartels-Rutten, A., Aleman, B.M.P., van Hillegersberg, R., Ruurda, J.P., et al.(2018). DW-MRI and DCE-MRI are of complementary value in predicting pathologic response to neoadjuvant chemoradiotherapy for esophageal cancer . Acta Oncologica. 57. (9). p. 1201-1208.
Seesing, M.F.J., Wirsching, A., Van Rossum, P.S.N., Weijs, T.J., Ruurda, J.P., Van Hillegersberg, R., Low, D.E.(2018). Defining pneumonia after esophagectomy for cancer: Validation of the Uniform Pneumonia Score in a high volume center in North America . Diseases of the Esophagus. 31. (6).
Kroese, T.E., Goense, L., Van Hillegersberg, R., De Keizer, B., Mook, S., Ruurda, J.P., Van Rossum, P.S.N.(2018). Detection of distant interval metastases after neoadjuvant therapy for esophageal cancer with <sup>18</sup> F-FDG PET(/CT): A systematic review and meta-analysis . Diseases of the Esophagus. 31. (12).
Borggreve, A.S., Goense, L., van Rossum, P.S.N., van Hillegersberg, R., de Jong, P.A., Ruurda, J.P.(2018). Generalized cardiovascular disease on a preoperative CT scan is predictive for anastomotic leakage after esophagectomy . European Journal of Surgical Oncology. 44. (5). p. 587-593.
Goense, L., Meziani, J., Van Rossum, P.S.N., Wessels, F.J., Meijer, G.J., Lam, M.G.E.H., Van Hillegersberg, R., Ruurda, J.P.(2018). Limited additional value of cervical ultrasonography over a negative <sup>18</sup>F-FDG PET/CT for diagnosing cervical lymph node metastases in patients with esophageal cancer: A systematic review and meta-analysis . Nuclear Medicine Communications. 39. (7). p. 645-651.
Goense, L., Borggreve, A.S., Heethuis, S.E., Van Lier, A.L.H.M.W., Van Hillegersberg, R., Mook, S., Meijer, G.J., Van Rossum, P.S.N., Ruurda, J.P.(2018). Patient perspectives on repeated MRI and PET/CT examinations during neoadjuvant treatment of esophageal cancer . British Journal of Radiology. 91. (1086).
Goense, L., van Rossum, P.S.N., Xi, M., Maru, D.M., Carter, B.W., Meijer, G.J., Ho, L., van Hillegersberg, R., Hofstetter, W.L., Lin, S.H.(2018). Preoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal Adenocarcinoma . Annals of Surgical Oncology. 25. (6). p. 1598-1607.
Borggreve, A.S., Mook, S., Verheij, M., Mul, V.E.M., Bergman, J.J., Bartels-Rutten, A., Ter Beek, L.C., Beets-Tan, R.G.H., Bennink, R.J., Van Berge Henegouwen, M.I., et al.(2018). Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): A multicenter observational study . BMC Cancer. 18. (1).
Heethuis, S.E., Borggreve, A.S., Goense, L., Van Rossum, P.S.N., Mook, S., Van Hillegersberg, R., Ruurda, J.P., Meijer, G.J., Lagendijk, J.J.W., Van Lier, A.L.H.M.W.(2018). Quantification of variations in intra-fraction motion of esophageal tumors over the course of neoadjuvant chemoradiotherapy based on cine-MRI . Physics in Medicine and Biology. 63. (14).
Goense, L., Meziani, J., Borggreve, A.S., Van Rossum, P.S., Meijer, G.J., Ruurda, J.P., Van Hillegersberg, R., Weusten, B.L.(2018). Role of Adjuvant chemoradiotherapy after endoscopic treatment of early-stage esophageal cancer: A systematic review . Minerva Chirurgica. 73. (4). p. 428-436.
Goense, L., Visser, E., Haj Mohammad, N., Mook, S., Verhoeven, R.H.A., Meijer, G.J., van Rossum, P.S.N., Ruurda, J.P., van Hillegersberg, R.(2018). Role of neoadjuvant chemoradiotherapy in clinical T2N0M0 esophageal cancer: A population-based cohort study . European Journal of Surgical Oncology. 44. (5). p. 620-625.
Van Rossum, P.S.N., Mohammad, N.H., Vleggaar, F.P., Van Hillegersberg, R.(2018). Treatment for unresectable or metastatic oesophageal cancer: Current evidence and trends . Nature Reviews Gastroenterology and Hepatology. 15. (4). p. 235-249.
Brenkman, H.J.F., Visser, E., van Rossum, P.S.N., Siesling, S., van Hillegersberg, R., Ruurda, J.P.(2017). Association Between Waiting Time from Diagnosis to Treatment and Survival in Patients with Curable Gastric Cancer: A Population-Based Study in the Netherlands . Annals of Surgical Oncology. 24. (7). p. 1761-1769.
Goense, L., Stassen, P.M.C., Wessels, F.J., van Rossum, P.S.N., Ruurda, J.P., van Leeuwen, M.S., van Hillegersberg, R.(2017). Diagnostic performance of a CT-based scoring system for diagnosis of anastomotic leakage after esophagectomy: comparison with subjective CT assessment . European Radiology. 27. (10). p. 4426-4434.
Goense, L., van Dijk, W.A., Govaert, J.A., van Rossum, P.S.N., Ruurda, J.P., van Hillegersberg, R.(2017). Hospital costs of complications after esophagectomy for cancer . European Journal of Surgical Oncology. 43. (4). p. 696-702.
Visser, E., Rossum, P.S.N.V., Ruurda, J.P., Hillegersberg, R.V.(2017). Impact of Lymph Node Yield on Overall Survival in Patients Treated with Neoadjuvant Chemoradiotherapy Followed by Esophagectomy for Cancer . Annals of Surgery. 266. (5). p. 863-869.
Visser, E., Van Rossum, P.S.N., Verhoeven, R.H.A., Ruurda, J.P., Van Hillegersberg, R.(2017). Impact of Weekday of Esophagectomy on Short-term and Long-term Oncological Outcomes: A Nationwide Population-based Cohort Study in the Netherlands . Annals of Surgery. 266. (1). p. 76-81.
Visser, E., van Rossum, P.S.N., Leeftink, A.G., Siesling, S., van Hillegersberg, R., Ruurda, J.P.(2017). Impact of diagnosis-to-treatment waiting time on survival in esophageal cancer patients – A population-based study in The Netherlands . European Journal of Surgical Oncology. 43. (2). p. 461-470.
Goense, L., van Rossum, P.S.N., Tromp, M., Joore, H.C., van Dijk, D., Kroese, A.C., Ruurda, J.P., Van Hillegersberg, R.(2017). Intraoperative and postoperative risk factors for anastomotic leakage and pneumonia after esophagectomy for cancer . Diseases of the Esophagus. 30. (1). p. 1-10.
van Rossum, P.S.N., Haverkamp, L., Carvello, M., Ruurda, J.P., van Hillegersberg, R.(2017). Management and outcome of cervical versus intrathoracic manifestation of cervical anastomotic leakage after transthoracic esophagectomy for cancer . Diseases of the Esophagus. 30. (1). p. 1-8.
Goense, L., van der Sluis, P.C., van Rossum, P.S.N., van der Horst, S., Meijer, G.J., Haj Mohammad, N., van Vulpen, M., Mook, S., Ruurda, J.P., van Hillegersberg, R.(2017). Perioperative chemotherapy versus neoadjuvant chemoradiotherapy for esophageal or GEJ adenocarcinoma: A propensity score-matched analysis comparing toxicity, pathologic outcome, and survival . Journal of Surgical Oncology. 115. (7). p. 812-820.
Visser, E., Marsman, M., van Rossum, P.S.N., Cheong, E., Al-Naimi, K., van Klei, W.A., Ruurda, J.P., van Hillegersberg, R.(2017). Postoperative pain management after esophagectomy: A systematic review and meta-analysis . Diseases of the Esophagus. 30. (10). p. 1-11.
Samim, M., Molenaar, I.Q., Seesing, M.F.J., van Rossum, P.S.N., van den Bosch, M.A.A.J., Ruers, T.J.M., Borel Rinkes, I.H.M., van Hillegersberg, R., Lam, M.G.E.H., Verkooijen, H.M.(2017). The diagnostic performance of <sup>18</sup>F-FDG PET/CT, CT and MRI in the treatment evaluation of ablation therapy for colorectal liver metastases: A systematic review and meta-analysis . Surgical Oncology. 26. (1). p. 37-45.
Parry, K., van Rossum, P.S.N., Haj Mohammad, N., Ruurda, J.P., van Hillegersberg, R.(2017). The effect of perioperative chemotherapy for patients with an adenocarcinoma of the gastroesophageal junction: A propensity score matched analysis . European Journal of Surgical Oncology. 43. (1). p. 226-233.
van Rossum, P.S.N., Fried, D.V., Zhang, L., Hofstetter, W.L., Ho, L., Meijer, G.J., Carter, B.W., Court, L.E., Lin, S.H.(2017). The value of <sup>18</sup>F-FDG PET before and after induction chemotherapy for the early prediction of a poor pathologic response to subsequent preoperative chemoradiotherapy in oesophageal adenocarcinoma . European Journal of Nuclear Medicine and Molecular Imaging. 44. (1). p. 71-80.
Weijs, T.J., Goense, L., van Rossum, P.S.N., Meijer, G.J., van Lier, A.L.H.M.W., Wessels, F.J., Braat, M.N.G., Lips, I.M., Ruurda, J.P., Cuesta, M.A., et al.(2017). The peri-esophageal connective tissue layers and related compartments: visualization by histology and magnetic resonance imaging . Journal of Anatomy. 230. (2). p. 262-271.
Peter S.N. van Rossum, Lucas Goense, Jihane Meziani, Johannes B. Reitsma, Peter D. Siersema, Frank P. Vleggaar, Marco van Vulpen, Gert J. Meijer, Jelle P. Ruurda, Richard van Hillegersberg(2016). Endoscopic biopsy and EUS for the detection of pathologic complete response after neoadjuvant chemoradiotherapy in esophageal cancer: a systematic review and meta-analysis . Gastrointestinal Endoscopy. 83. (5). p. 866--879. Elsevier {BV}
Weijs, T.J., Seesing, M.F.J., van Rossum, P.S.N., Ko&#235;ter, M., van der Sluis, P.C., Luyer, M.D.P., Ruurda, J.P., Nieuwenhuijzen, G.A.P., van Hillegersberg, R.(2016). Internal and External Validation of a multivariable Model to Define Hospital-Acquired Pneumonia After Esophagectomy . Journal of Gastrointestinal Surgery. 20. (4). p. 680-687.
Kechagias, A., Van Rossum, P.S.N., Ruurda, J.P., Van Hillegersberg, R.(2016). Ischemic Conditioning of the Stomach in the Prevention of Esophagogastric Anastomotic Leakage after Esophagectomy . Annals of Thoracic Surgery. 101. (4). p. 1614-1623.
Kechagias, A., van Rossum, P.S.N.(2016). Letter to the Editor on the article “The role of low CRP values in the prediction of the development of acute diverticulitis” . International Journal of Colorectal Disease. 31. (9). p. 1667-1668.
Peters, M., Van Der Voort Van Zyp, J.R.N., Moerland, M.A., Hoekstra, C.J., Van De Pol, S., Westendorp, H., Maenhout, M., Kattevilder, R., Verkooijen, H.M., Van Rossum, P.S.N., et al.(2016). Multivariable model development and internal validation for prostate cancer specific survival and overall survival after whole-gland salvage Iodine-125 prostate brachytherapy . Radiotherapy and Oncology. 119. (1). p. 104-110.
Goense, L., van Rossum, P.S.N., Ruurda, J.P., van Vulpen, M., Mook, S., Meijer, G.J., van Hillegersberg, R.(2016). Radiation to the Gastric Fundus Increases the Risk of Anastomotic Leakage After Esophagectomy . Annals of Thoracic Surgery. 102. (6). p. 1798-1804.
van Rossum, P.S.N., Xu, C., Fried, D.V., Goense, L., Court, L.E., Lin, S.H.(2016). The emerging field of radiomics in esophageal cancer: Current evidence and future potential . Translational Cancer Research. 5. (4). p. 410-423.
Van Rossum, P.S.N., Fried, D.V., Zhang, L., Hofstetter, W.L., Van Vulpen, M., Meijer, G.J., Court, L.E., Lin, S.H.(2016). The incremental value of subjective and quantitative assessment of <sup>18</sup>F-FDG PET for the prediction of pathologic complete response to preoperative chemoradiotherapy in esophageal cancer . Journal of Nuclear Medicine. 57. (5). p. 691-700.
Visser, E., Leeftink, A.G., van Rossum, P.S.N., Siesling, S., van Hillegersberg, R., Ruurda, J.P.(2016). Waiting Time from Diagnosis to Treatment has no Impact on Survival in Patients with Esophageal Cancer . Annals of Surgical Oncology. 23. (8). p. 2679-2689.
Peters, M., van der Voort van Zyp, J.R.N., Moerland, M.A., Hoekstra, C.J., van de Pol, S., Westendorp, H., Maenhout, M., Kattevilder, R., Verkooijen, H.M., van Rossum, P.S.N., et al.(2016). Development and internal validation of a multivariable prediction model for biochemical failure after whole-gland salvage iodine-125 prostate brachytherapy for recurrent prostate cancer . Brachytherapy. 15. (3). p. 296-305.
Heethuis, S.E., van Rossum, P.S.N., Lips, I.M., Goense, L., Voncken, F.E., Reerink, O., van Hillegersberg, R., Ruurda, J.P., Philippens, M.E., van Vulpen, M., et al.(2016). Dynamic contrast-enhanced MRI for treatment response assessment in patients with oesophageal cancer receiving neoadjuvant chemoradiotherapy . Radiotherapy and Oncology. 120. (1). p. 128-135.
Van Rossum, P.S.N., Goense, L., Meziani, J., Reitsma, J.B., Siersema, P.D., Vleggaar, F.P., Van Vulpen, M., Meijer, G.J., Ruurda, J.P., Van Hillegersberg, R.(2016). Endoscopic biopsy and EUS for the detection of pathologic complete response after neoadjuvant chemoradiotherapy in esophageal cancer: A systematic review and meta-analysis . Gastrointestinal Endoscopy. 83. (5). p. 866-879.
Goense, L., Van Rossum, P.S.N., Weijs, T.J., Van Det, M.J., Nieuwenhuijzen, G.A., Luyer, M.D., Van Leeuwen, M.S., Van Hillegersberg, R., Ruurda, J.P., Kouwenhoven, E.A.(2016). Aortic Calcification Increases the Risk of Anastomotic Leakage after Ivor-Lewis Esophagectomy . Annals of Thoracic Surgery. 102. (1). p. 247-252.
Van Rossum, P.S.N., Haverkamp, L., Verkooijen, H.M., Van Leeuwen, M.S., Van Hillegersberg, R., Ruurda, J.P.(2015). Calcification of arteries supplying the gastric tube: A new risk factor for anastomotic leakage after esophageal surgery . Radiology. 274. (1). p. 124-132.
Van Rossum, P.S.N., Goense, L., Van Hillegersberg, R., Ruurda, J.P.(2015). Comment on: Hölscher AH, Bollschweiler E, Bogoevski D, Schmidt H, Semrau R, Izbicki JR. Prognostic impact of neoadjuvant chemoradiation in cT3 oesophageal cancer - A propensity score matched analysis. Eur J Cancer. 2014;50(17):2950-7 . European Journal of Cancer. 51. (14). p. 2095-2096.
Goense, L., Van Rossum, P.S.N., Reitsma, J.B., Lam, M.G.E.H., Meijer, G.J., Van Vulpen, M., Ruurda, J.P., Van Hillegersberg, R.(2015). Diagnostic performance of <sup>18</sup>F-FDG PET and PET/CT for the detection of recurrent esophageal cancer after treatment with curative intent: A systematic review and meta-analysis . Journal of Nuclear Medicine. 56. (7). p. 995-1002.
Van Rossum, P.S.N., Van Lier, A.L.H.M.W., Van Vulpen, M., Reerink, O., Lagendijk, J.J.W., Lin, S.H., Van Hillegersberg, R., Ruurda, J.P., Meijer, G.J., Lips, I.M.(2015). Diffusion-weighted magnetic resonance imaging for the prediction of pathologic response to neoadjuvant chemoradiotherapy in esophageal cancer . Radiotherapy and Oncology. 115. (2). p. 163-170.
Van Rossum, P.S.N., Van Lier, A.L.H.M.W., Lips, I.M., Meijer, G.J., Reerink, O., Van Vulpen, M., Lam, M.G.E.H., Van Hillegersberg, R., Ruurda, J.P.(2015). Imaging of oesophageal cancer with FDG-PET/CT and MRI . Clinical Radiology. 70. (1). p. 81-95.
Akkerman, R.D.L., Haverkamp, L., Van Rossum, P.S.N., Van Hillegersberg, R., Ruurda, J.P.(2015). Long-term quality of life after oesophagectomy with gastric conduit interposition for cancer . European Journal of Cancer. 51. (12). p. 1538-1545.
Van Rossum, P.S.N., Van Hillegersberg, R., Reerink, O., Ruurda, J.P.(2015). Neoadjuvant chemoradiotherapy for stage I and II esophageal cancer . Journal of Clinical Oncology. 33. (3). p. 287-288.
Parry, K., Visser, E., van Rossum, P.S.N., Mohammad, N.H., Ruurda, J.P., van Hillegersberg, R.(2015). Prognosis and Treatment After Diagnosis of Recurrent Esophageal Carcinoma Following Esophagectomy with Curative Intent . Annals of Surgical Oncology. 22. p. 1292-1300.
Van Rossum, P.S.N., Van Hillegersberg, R., Meijer, G.J., Ruurda, J.P.(2015). Residual esophageal cancer after neoadjuvant chemoradiotherapy frequently involves the mucosa and submucosa . Annals of Surgery. 262. (2). p. e83-e84.
Waaijer, L., Kreb, D.L., Fernandez Gallardo, M.A., Van Rossum, P.S.N., Postma, E.L., Koelemij, R., Van Diest, P.J., Klaessens, J.H.G.M., Witkamp, A.J., Van Hillegersberg, R.(2014). Radiofrequency ablation of small breast tumours: Evaluation of a novel bipolar cool-tip application . European Journal of Surgical Oncology. 40. (10). p. 1222-1229.
Van Rossum, P.S.N., Van Hillegersberg, R., Lever, F.M., Lips, I.M., Van Lier, A.L.H.M.W., Meijer, G.J., Van Leeuwen, M.S., Van Vulpen, M., Ruurda, J.P.(2013). Imaging strategies in the management of oesophageal cancer: What's the role of MRI? . European Radiology. 23. (7). p. 1753-1765.
Van Esser, S., Madsen, E.V.E., Van Dalen, T., Koelemij, R., Van Rossum, P.S.N., Borel Rinkes, I.H.M., Van Hillegersberg, R., Witkamp, A.J.(2011). Axillary staging in breast cancer patients with exclusive lymphoscintigraphic drainage to the internal mammary Chain . World Journal of Surgery. 35. (1). p. 159-164.
PREPRINT
Palma DA, Giuliani ME, Correa RJM, Schneiders FL, Harrow S, Guckenberger M, Zhang T, Bahig H, Senthi S, Chung P, et al.(2024). A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients with Up to 10 Oligometastases and a Synchronous Primary Tumor (SABR-SYNC): Study Protocol .
OTHER
Palma, D.A., Giuliani, M.E., Correa, R.J.M., Schneiders, F.L., Harrow, S., Guckenberger, M., Zhang, T., Bahig, H., Senthi, S., Chung, P., et al.(2024). A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients with Up to 10 Oligometastases and a Synchronous Primary Tumor (SABR-SYNC): Study Protocol . Research Square.
CONFERENCE PAPER
Kroese, T.E., Dijksterhuis, W.P.M., van Rossum, P.S.N., Verhoeven, R.H.A., Mook, S., Haj Mohammad, N., Hulshof, M.C.C.M., van Berge Henegouwen, M.I., van Oijen, M.G.H., Ruurda, J.P., et al.(2022). Prognosis of Interval Distant Metastases After Neoadjuvant Chemoradiotherapy for Esophageal Cancer . Annals of Thoracic Surgery. 113. (2). p. 482-490.
BOOK
Goense, L., van Rossum, P.S.N., Kandioler, D., Ruurda, J.P., Goh, K.-L., Luyer, M.D., Krasna, M.J., van Hillegersberg, R.(2016). Stage-directed individualized therapy in esophageal cancer . Annals of the New York Academy of Sciences. 1381. (1). p. 50-65.
Blom, R.L.G.M., Bogush, T., Br&#252;cher, B.L.D.M., Chang, A.C., Davydov, M., Dudko, E., Leong, T., Polotsky, B., Swanson, P.E., van Rossum, P.S.N., et al.(2014). Therapeutic approaches to gastroesophageal junction adenocarcinomas . Annals of the New York Academy of Sciences. 1325. (1). p. 197-210.
Wijnhoven, B.P.L., Toxopeus, E.L.A., Vallb&#246;hmer, D., Knoefel, W.T., Krasna, M.J., Perez, K., van Rossum, P.S.N., Ruurda, J.P., van Hillegersberg, R., Schiesser, M., et al.(2013). New therapeutic strategies for squamous cell cancer and adenocarcinoma . Annals of the New York Academy of Sciences. 1300. (1). p. 213-225.